Toll-like receptors

Clinical and Basic Immunodermatology

Volumn , Issue , 2008, Pages 67-84

  Martin, Donna Bilu ^a   Gaspari, Anthony A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65249152714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84800-165-7_5     Document Type: Chapter

References (106)

1. Bilu D, Sauder D. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000;43(1 pt 2):S6-11
2. Fuchs E, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996;8(5): 271-280
3. Gaspari A. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006;54(3 suppl 2):S67-80
4. Beutler B. Toll-like receptors: How they work and what they do. Curr Opin Hematol 2002;9(1):2-10
5. Kang S, Kauls L, Gaspari A. Toll-like receptors: Applications to dermatologic disease. J Am Acad Dermatol 2006;54(6):951-983
6. Lemaitre B, Nicolas E, Michaut L, et al. The dorsoventral regulatory gene cassette Spatze/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86(6):973-983
7. Armant M, Fenton M. Toll-like receptors: A family of pattern-recognition receptors in mammals. Genome Biol 2002;3(8):reviews 3011
8. Zhang D, Zhang G, Hayden M. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303(5663):1522-1526
9. McGirt L, Beck L. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006;118(1): 202-208
10. Sieling P, Modlin R. Toll-like receptors: Mammalian 'taste receptors' for a smorgasbord of microbial invaders. Curr Opin Microbiol 2002;5(1):70-75
11. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature 1998;392(6673): 245-252
12. Beg A. Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol 2002;23(11):509-512
13. Berwin B, Reed R, Nicchitta C. Virally induced lytic cell death elicits the release of immunogenic GRP94/ gp96. J Biol Chem 2001;276(21):21083-21088
14. Akira S. Toll-like receptors and innate immunity. Adv Immunol 2001;78:1-56
15. Hemmi H, Kaisho T, Takeuchi O, et al. Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002;3(2):196-200
16. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2(8):675-680
17. Bulut Y, Faure E, Thomas L, et al. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Tollinteracting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001;167(2):987-994
18. Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001;167(10): 5887-5894
19. Sato M, Taniguchi T, Tanaka N. The interferon system and interferon regulatory factor transcription factors: Studies from gene knockout mice. Cytokine Growth Factor Rev 2001;12(2-3):133-142
20. Taniguchi T, Takaoka A. The interferon-Alpha/beta system in antiviral responses: A multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002;14(1):111-116
21. Kaisho T, Takeuchi O, Kawai T, et al. Endotoxin induced maturation of MyD88-deficient dendritic cells. J Immunol 2001;166(9):5688-5694
22. Seki E, Tsutsui H, Nakano H, et al. Lipopolysaccharide induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol 2001;166(4): 2651-2657
23. Strauss J, Kligman A. The pathologic dynamics of acne vulgaris. Arch Dermatol 1960;82:779-791
24. Ingham E, Eady E, Goodwin C, et al. Pro-inflammatory levels of interleukin-1-Alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992;98(6):895-901
25. Vowels B, Yang S, Leyden J. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect Immun 1995;63(8): 3158-3165
26. Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006;8(8):2195-2205
27. Boehm K, Yun J, Strohl K, et al. Messenger RNA for the multifunctional cytokines interleukin-1alpha, interleukin-1beta, and tumor necrosis factor-Alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol 1995;4(6):335-341
28. Schroder J. Epithelial peptide antibiotics. Biochem Pharmacol 1999;57(2):121-134
29. Yang D CO, Bykovskaia SN, et al. Beta-defensins: Linking innate and Adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-528
30. Kim J, Ochoa M, Krutzik S, et al. Activation of tolllike receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169(3):1535-1541
31. Yang R, Mark M, Gurney A, et al. Signaling events induced by lipopolysaccharide-Activated Toll-like receptor 2. J Immunol 1999;163(2):639-643
32. Vega B, Ferret C, Jomard A. Regulation of Toll-Like receptor-2 expression by Adapalene: Implications for the treatment of inflammatory acne. J Invest Dermatol Abstracts 2003;121:156
33. Bochud P, Hawn T, Aderem A. Cutting edge: A Toll-Like Receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003;170(7):3451-3454
34. Underhill D, Orzinsky A, Smith K, et al. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999;96(25):14459-14463
35. Kang T, Chae G. Detection of Toll-like Receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001;31(1):53-58
36. Kang T, Yeum C, Kim B, et al. Differential production of IL-10 and IL-12 in mononuclear cells from leprosy patients with a Toll-like Receptor 2 mutation. Immunol 2004;112(4):674-680
37. Krutzik S, Ochoa M, Sieling P, et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nature Med 2003;9(5):525-532
38. Bouis D, Popva T, Takashim A, et al. Dendritic cells phagocytose and are activated by Treponema pallidum. Infect Immun 2001;69(1):518-528
39. Means T, Hayashi F, Smith K. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 2003;170(10):5165-5175
40. Mizel S, Honko A, Moors M, et al. Induction of macrophage nitric oxide production by gram-negative flagellin involves signaling via heteromeric Toll-like receptor5/Toll-like receptor4 complexes. J Immunol 2003;170(12):6217-6223
41. Leung D. Infection in atopic dermatitis. Curr Opin Pediatr 2003;15(4):399-404
42. Cho S, Strickland I, Tomkinson A, et al. Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol 2001;116(5):658-663
43. Ong P, Ohtake T, Brandt C. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347(15):1151-1160
44. Birchler T, Seibel R, Buchner K, et al. Human Tolllike receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 2001;31(11): 3131-3137
45. Biragyn A, Ruffini P, Leifer C, et al. Tolllike receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002;298(5595): 1025-1029
46. Werfel T, Heeg K, Neumaier M, et al. R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004;113(3):565-567
47. Ou L-S, Goleva E, Hall C, et al. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004;113(4):756-763
48. Miller L, O'Connell R, Gutierrez M, et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 2006;24(1): 79-91
49. Piggott D, Eisenbarth S, Xu L. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest 2005;115(2):459-467
50. Baker B, Ovigne J-M, Powles A, et al. Normal keratinocytes express Toll-Like receptors (TLRs) 1, 2 and 5: Modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003;148(4): 670-679
51. Curry J, Qin J-Z, Bomish B, et al. Innate immunerelated receptors in normal and psoriatic skin. Arch Pathol Lab Med 2003;127(2):178-186
52. Litjens N, Rademaker M, Ravensbergen B, et al. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol 2004;34(2):565-575
53. Gilliet M, Conrad C, Geiges M, et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004;140(12):1490-1495
54. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect 1989;159(2):195-204
55. Ingalls R, Lien E, Golenbock D. Differential roles of TLR2 and TLR4 in the host response to gram-negative bacteria: Lessons from a lipopolysaccharide- deficient mutant of Neisseria meningitidis. J Endotoxin Res 2000;6(5):411-415
56. Massari P, Henneke P, Ho Y, et al. Cutting edge: Immune stimulation by neisserial porins is Tolllike receptor 2 and MyD88 dependent. J Immunol 2002;168(4):1533-1537
57. Al-Bader T, Christodoulides M, Heckels J, et al. Activation of human dendritic cells in modulated by components of the outer membranes of Neisseria meningitidis. Infect Immun 2003;71(10): 5590-5597
58. Mullarkey M, Rose J, Bristol J, et al. Inhibition of endotoxin response by E5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharm Exp Ther 2003;304(3):1093-1102
59. Sing A, Roggenkamp A, Geiger A, et al. Yersinia enterolitica evasion of the host innate immune response by V antigen-induced-IL-10 production of macrophages is abrogated in IL-10 deficient mice. J Immunol 2002;168(3):1315- 1321
60. Sing A, Rost D, Tvardovaskia N, et al. Yersinia Vantigen exploits Toll-Like Receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002;196(8):1017-1024
61. Haase R, Kirsching C, Sing A, et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol 2003;171(8):4294-4303
62. Wang G, Li C, Zu Y, et al. The role of activation of Toll-like receptors in immunological pathogenesis of Kawasaki disease. Zhonghua Er Ke Za Zhi 2006;44(5):333-336
63. Hirschfeld M, Kirschning C, Schwandner R, et al. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999;163(5):2382-2386
64. Cassiani-Ingoni R, Cabral E, Lunemann J, et al. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J Neuropathol Exp Neurol 2006;65(6):540-548
65. Picard C, Puel A, Bonnet M. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003;299(5615):2076-2079
66. Underhill D, Ozinsky A, Hajjar A, et al. The Tolllike receptor 2 is recruited to macrophage phagosome and discriminates between pathogens. Nature 1999;401(6755):811-815
67. Tada H, Nemoto E, Shimauchi H, et al. Saccharomyces cerevisiae-And Candida albicans-derived mannan production of tumor necrosis factor alpha by human monocytes in a CD14-And Toll-like receptor 4-dependent manner. Microbiol Immunol 2002;46(7):503-512
68. Netea M, Van Der Graaf C, Vonk A, et al. The role of Toll-like receptor (TLR 2) and TLR 4 in the host defense against disseminated candidiasis. J Infect Dis 2002;185(10):1483-1489
69. Deva R, Shankaranarayanan P, Ciccoli R, et al. Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: Pivotal roles of toll-like receptors, p38 mitogen-Activated protein kinases, and NF-kappaB. J Immunol 2003;171(6):3047-3055
70. Kurt-Jones E, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004;101:1315-1320
71. Krug A, Luker G, Barchet W. Herpes simplex virus type 1 activates murine natural interferonproducing cells through toll-like receptor 9. Blood 2004;103(4):1433-1437
72. Herbst-Kralovetz M, Pyles R. Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 2006;13(2):37-41
73. Alexopoulou L, Holt A, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413(6857):732-738
74. McCluskie M, Cartier J, Patrick A, et al. Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848). Antiviral Res 2006;69(2):77-85
75. Ding C, Wang L, Al-Ghawi H, et al. Toll-like receptor engagement stimulates anti-snRNP autoreactive T cells for activation. Eur J Immunol 2006;36(8): 2013-2024
76. Rutz M, Metzger J, Gellert T. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequenceand pH-dependent manner. Eur J Immunol 2004;34(9):2541-2550
77. Vollmer J, Tluk S, Schmitz C, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005;202(11):1575-1585
78. Patole P, Pawar R, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 2006;21(11):3062-73
79. Clarke J, Cha J, Walsh M, et al. Melanoma inhibits macrophage activation by suppressing Toll-like receptor 4 signaling. J Am Coll Surg 2005;201(3):418-425
80. Molteni M, Marabella D, Orlandi C, et al. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett 2006;235(1):75-83
81. Tormo D, Ferrer A, Bosch P. Therapeutic efficacy of antigen-specific vaccination and Toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice. Cancer Res 2006;66(10):5427-5435
82. Na. CpG 7909: PF 3512676, PF-3512676. Drugs in Research and Development 2006;7(5):312-316
83. Deeths M, Chapman J, Dellavalle R. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream. J Am Acad Dermatol 2005;52(2):275-280
84. Rivas J, Ullrich S. Systemic suppression of delayed-Type hypersensitivity by supernatants from UV-induced keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992;149(12):3865-3871
85. Yoshikawa T, Kurimoto I, Streilein J. Tumor necrosis factor-Alpha mediates ultraviolet B-enhanced expression of contact hypersensitivity. Immunology 1992;76(2):254-271
86. Thatcher T, Luzina I, Fishelevich R, et al. Topical imiquimod treatment presents UV-light induced loss of contact hypersensitivity and immune tolerance. J Invest Dermatol 2006;126(4):821-831
87. Gaspari A, Fleisher T, Karemer K. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993;92(3): 1135-1142
88. Anderson KV, Bokla L, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: The induction of polarity by the Toll gene product. Cell 1985;42:791-798
89. Janeway C Jr Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 1989;54(Pt 1):1-13
90. Medzhitov R, Preston-Hurlburt P, Janeway C Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388(24):394-397
91. Beutler B, Poltorak A. The sole gateway endotoxin response: How LPS was identified as TLR 4 and its role in innate immunity. Drug Metab Dispos 2001;29(4 pt 2):474-478
92. Hemmi H, Takeuchi O, Kawai T, et al. A Tolllike receptor recognizes bacterial DNA. Nature 2000;408(6813):740-745
93. Ozinsky A, Underhill D, JD F, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771
94. Hayashi F, Smith K, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410(6832): 1099-1103
95. Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001;291(5508):1544-1547
96. Alexopoulou L, Thomas V, Schnare M, et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-And TLR2-deficient mice. Nat Med 2002;8(8): 878-884
97. Pivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003;15(6):721-730
98. Mempel M, Voelcker V, Kollisch G, et al. Tolllike receptor expression in human keratinocytes: Nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 2003;121(6): 1389-1396
99. Heil F, Hemmi H, Hochrein H, et al. Speciesspecific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2003;303(5663): 1526-1529
100. Tabeta K, Georgel P, Janssen E, et al. Toll like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection 3. Proc Natl Acad Sci USA 2004;101(10):3516-3521
101. Mitsui H, Watanabe T, Saeki H, et al. Differential expression and function of Toll-like receptors in Langerhans cells: Comparison with splenic dendritic cells. J Invest Dermatol 2004;122(1): 95-102
102. Bsibsi M, Persoon-Deen C, Verwer R, et al. Tolllike receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006;53(7):688-695
103. Martin-Armas M, Simon-Santamaria J, Pettersen I. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J Hepatol 2006;44(5):939-946
104. Supajatura V, Ushio H, Nakao A. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002;109(10):1351-1359
105. Kurt-Jones E, Sandor F, Ortiz Y, et al. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J Endotox Res 2004;10(6):419-424
106. Majewska M, Szczepanik M. The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation. Postepy Hig Med Dosw 2006;60: 52-63